开云app官网登录入口网页版-官方正版

#阿来替尼#

3篇内容 | 1381人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2223510, encodeId=ab22222351033, content=<a href='/topic/show?id=32af9938ec6' target=_blank style='color:#2F92EE;'>#非小细胞肺癌#</a> <a href='/topic/show?id=be329e849f6' target=_blank style='color:#2F92EE;'>#阿来替尼#</a>, objectTitle=吴一龙教授团队携全球研究再次登顶NEJM！阿来替尼辅助治疗ALK阳性非小细胞肺癌疗效显著, objectType=article, longId=841409, objectId=6bef841409c6, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240731/1722406154575_8538692.png, objectUrl=/article/show_article.do?id=6bef841409c6, replyNumber=0, likeNumber=20, createdTime=2024-09-01, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=6bef841409c6, moduleTitle=吴一龙教授团队携全球研究再次登顶NEJM！阿来替尼辅助治疗ALK阳性非小细胞肺癌疗效显著, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=6bef841409c6)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2200401, encodeId=96cc220040155, content=<a href='/topic/show?id=384b8220449' target=_blank style='color:#2F92EE;'>#肺癌#</a> <a href='/topic/show?id=be329e849f6' target=_blank style='color:#2F92EE;'>#阿来替尼#</a>, objectTitle=指南更新 | 阿来替尼辅助治疗ALK阳性早期肺癌获非小细胞肺癌NCCN指南（2024.V5）推荐！, objectType=article, longId=819080, objectId=082f8190802b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-writing-prescription-or-medical-PDEMCBW.jpg, objectUrl=/article/show_article.do?id=082f8190802b, replyNumber=0, likeNumber=71, createdTime=2024-04-25, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=082f8190802b, moduleTitle=指南更新 | 阿来替尼辅助治疗ALK阳性早期肺癌获非小细胞肺癌NCCN指南（2024.V5）推荐！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=082f8190802b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2199872, encodeId=5fe521998e240, content=<a href='/topic/show?id=2493130e1a1' target=_blank style='color:#2F92EE;'>#NSCLC#</a> <a href='/topic/show?id=f6f5536422e' target=_blank style='color:#2F92EE;'>#慢性肾病#</a> <a href='/topic/show?id=92451012183b' target=_blank style='color:#2F92EE;'>#饮食#</a> <a href='/topic/show?id=1a17528644d' target=_blank style='color:#2F92EE;'>#恩格列净#</a> <a href='/topic/show?id=be329e849f6' target=_blank style='color:#2F92EE;'>#阿来替尼#</a> <a href='/topic/show?id=30fc10822031' target=_blank style='color:#2F92EE;'>#四大顶刊#</a>, objectTitle=‘四大顶刊’一周研究导读：蛋白质、脂肪、碳水、膳食纤维“最佳”饮食最佳方案；阿来替尼在可切除ALK阳性NSCLC辅助治疗中展现显著疗效；恩格列净显著降低各种原发性慢性肾病进展风险, objectType=article, longId=822810, objectId=cb6182281010, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221201/1669967681394_4754896.webp, objectUrl=/article/show_article.do?id=cb6182281010, replyNumber=0, likeNumber=112, createdTime=2024-04-22, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=cb6182281010, moduleTitle=‘四大顶刊’一周研究导读：蛋白质、脂肪、碳水、膳食纤维“最佳”饮食最佳方案；阿来替尼在可切除ALK阳性NSCLC辅助治疗中展现显著疗效；恩格列净显著降低各种原发性慢性肾病进展风险, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=cb6182281010)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2198769, encodeId=f0702198e6947, content=<a href='/topic/show?id=2493130e1a1' target=_blank style='color:#2F92EE;'>#NSCLC#</a> <a href='/topic/show?id=540623233e' target=_blank style='color:#2F92EE;'>#ALK阳性#</a> <a href='/topic/show?id=be329e849f6' target=_blank style='color:#2F92EE;'>#阿来替尼#</a>, objectTitle=NEJM：阿来替尼在可切除ALK阳性NSCLC辅助治疗中展现显著疗效, objectType=article, longId=821750, objectId=c959821e50f7, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240415/1713189527320_6145188.png, objectUrl=/article/show_article.do?id=c959821e50f7, replyNumber=0, likeNumber=106, createdTime=2024-04-16, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c959821e50f7, moduleTitle=NEJM：阿来替尼在可切除ALK阳性NSCLC辅助治疗中展现显著疗效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c959821e50f7)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2193608, encodeId=2f64219360898, content=<a href='/topic/show?id=e62011236077' target=_blank style='color:#2F92EE;'>#洛拉替尼#</a> <a href='/topic/show?id=be329e849f6' target=_blank style='color:#2F92EE;'>#阿来替尼#</a> <a href='/topic/show?id=5e2e4e08988' target=_blank style='color:#2F92EE;'>#小细胞肺癌#</a>, objectTitle=首例：洛拉替尼成功治疗阿来替尼耐药的ALK阳性转化性小细胞肺癌患者, objectType=article, longId=817274, objectId=c40b81e27480, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/filling-medical-history-XZB9RVX.jpg, objectUrl=/article/show_article.do?id=c40b81e27480, replyNumber=0, likeNumber=91, createdTime=2024-03-16, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c40b81e27480, moduleTitle=首例：洛拉替尼成功治疗阿来替尼耐药的ALK阳性转化性小细胞肺癌患者, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c40b81e27480)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1413154, encodeId=a62d14131543b, content=<a href='/topic/show?id=be329e849f6' target=_blank style='color:#2F92EE;'>#阿来替尼#</a>, objectTitle=Thorac Cancer：克唑替尼-阿来替尼续贯方案治疗中国晚期ALK阳性NSCLC患者的疗效, objectType=article, longId=221572, objectId=bfd12215e24f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bfd12215e24f, replyNumber=0, likeNumber=96, createdTime=2021-12-07, rootId=0, userName=nymo, userId=55fa2946741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bfd12215e24f, moduleTitle=Thorac Cancer：克唑替尼-阿来替尼续贯方案治疗中国晚期ALK阳性NSCLC患者的疗效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=bfd12215e24f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1413153, encodeId=32651413153cc, content=<a href='/topic/show?id=be329e849f6' target=_blank style='color:#2F92EE;'>#阿来替尼#</a>, objectTitle=Cancer Sci：阿来替尼可有效且安全的治疗复发或难治的ALK阳性淋巴瘤, objectType=article, longId=212383, objectId=7fa221238379, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7fa221238379, replyNumber=0, likeNumber=122, createdTime=2021-06-08, rootId=0, userName=nymo, userId=55fa2946741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7fa221238379, moduleTitle=Cancer Sci：阿来替尼可有效且安全的治疗复发或难治的ALK阳性淋巴瘤, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=7fa221238379)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1413152, encodeId=a17d14131522d, content=<a href='/topic/show?id=be329e849f6' target=_blank style='color:#2F92EE;'>#阿来替尼#</a>, objectTitle=PLos One：阿来替尼与克唑替尼作为ALK+晚期非小细胞肺癌一线治疗的成本-疗效比较, objectType=article, longId=186445, objectId=bda2186445a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bda2186445a1, replyNumber=0, likeNumber=82, createdTime=2020-01-19, rootId=0, userName=nymo, userId=55fa2946741, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bda2186445a1, moduleTitle=PLos One：阿来替尼与克唑替尼作为ALK+晚期非小细胞肺癌一线治疗的成本-疗效比较, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=bda2186445a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

阿来替尼

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#非小细胞肺癌# #阿来替尼#

吴一龙教授团队携全球研究再次登顶NEJM！阿来替尼辅助治疗ALK阳性非小细胞肺癌疗效显著

2024-09-01发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#肺癌# #阿来替尼#

指南更新 | 阿来替尼辅助治疗ALK阳性早期肺癌获非小细胞肺癌NCCN指南（2024.V5）推荐！

2024-04-25发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#NSCLC# #慢性肾病# #饮食# #恩格列净# #阿来替尼# #四大顶刊#

‘四大顶刊’一周研究导读：蛋白质、脂肪、碳水、膳食纤维“最佳”饮食最佳方案；阿来替尼在可切除ALK阳性NSCLC辅助治疗中展现显著疗效；恩格列净显著降低各种原发性慢性肾病进展风险

2024-04-22发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#NSCLC# #ALK阳性# #阿来替尼#

NEJM：阿来替尼在可切除ALK阳性NSCLC辅助治疗中展现显著疗效

2024-04-16发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#洛拉替尼# #阿来替尼# #小细胞肺癌#

首例：洛拉替尼成功治疗阿来替尼耐药的ALK阳性转化性小细胞肺癌患者

2024-03-16发表于上海

nymo (审核中...)

前往app查看评论内容

#阿来替尼#

Thorac Cancer：克唑替尼-阿来替尼续贯方案治疗中国晚期ALK阳性NSCLC患者的疗效

2021-12-07

nymo (审核中...)

前往app查看评论内容

#阿来替尼#

Cancer Sci：阿来替尼可有效且安全的治疗复发或难治的ALK阳性淋巴瘤

2021-06-08

nymo (审核中...)

前往app查看评论内容

#阿来替尼#

PLos One：阿来替尼与克唑替尼作为ALK+晚期非小细胞肺癌一线治疗的成本-疗效比较

2020-01-19

科室
- - 订阅+
  - 更多科室
工具
服务